YUROXAN

MediGene AG

Application Filed: 2003-06-19

Trademark Application Details

Status

710

Dead/Cancelled

CANCELLED - SECTION 8

Research	OneLook Acronym Finder
Serial Number	78264418
Registration Number	2917240
Mark Drawing Code	1000: Typeset: Word(s)/letter(s)/number(s)
Cancellation Code	2
Domestic Representative	Burns, Doane, Swecker & Mathis, L.L.P.
Attorney Name	Adrienne L. White, Esq.
Attorney Docket Number	032861-011
Law Office Assigned	M30
Employee Name	LOHR, AMY C

Timeline

2003-06-19	Application Filed
2004-10-19	Published for Opposition
2005-01-11	Location: PUBLICATION AND ISSUE SECTION
2005-01-11	Trademark Registered
2014-09-03	Cancelled
2014-09-03	Status: Dead/Cancelled
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	MediGene AG
Address	Lochhamer Strasse 11 D-82152 Planegg/Ma DE
Legal Entity Type	Corporation
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Adrienne L White
WRB-IP LLP
P.O. Box 476
Wadsworth OH 44282

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	PHARMACEUTICAL AND VETERINARY MEDICAL PRODUCTS FOR MEDICAL PURPOSES, NAMELY, PHARMACEUTICAL PREPARATIONS FOR USE IN TREATING THE SKIN DISEASES OF WARTS, GENITAL WARTS, ACTINIC KERATOSIS, PSORIASIS, DERMATITIS, HERPES, ALOPECIA, ATOPIC DERMATITIS, CUTANEOUS ATOPY, CUTANEOUS T-CELL LYMPHOMA, DARRIER'S DISEASE, DARTROUD DISTHESIS, DERMATITIS, ECZEMA, GENITAL HERPES, HERPES, HYPERKERATOSIS, HYPERPIGMENTATION, HYPERPLASIA OF THE EPIDERMIS, HYPOPIGMENTATION, ICHTHYOSIS, INCREASED PROLIFERATION OF SKIN CELLS, KELOIDS, LENTIGO, LICHEN PLANUS, MELASMA, MOLLUSCUM, CONTAGIOSUM, MYCOSIS FUNGOIDES, NEOPLASIAS, NEURODERMITIS, PIGMENTATION DISORDERS, POROKERATOSIS OF MIBELLI, PSORIASIS, REMOVAL OF TATOOS, ROSACEA, SEBORRHEA, SHINGLES, SKIN DISEASES RELATED TO INFLAMMATORY PROCESSES OF SKIN CELLS, SKIN ULCERS, VITILIGO, WARTS, XEROSIS, AND MEDICATED SKIN PREPARATIONS FOR USE IN TREATING THE TUMOROUS DISEASES OF GLIOMA, CARCINOMA OF THE COLON, OVARIAN CARCINOMA, CERVICAL CARCINOMA, CARCINOMA OF THE PROSTATE, MELANOMA, ASTROCYTOMAS, BASEL CELL CARCINOMAS, BILIARY CANCERS, BLADDER CANCERS, BONE CANCERS, BRAIN CANCERS, BREAST CANCERS, CARCINOMAS, CERVICAL CANCERS, CERVICAL INTRAEPITHELIAL NEOPLASIAS, COLORECTAL CANCERS, ENDROCRINE SYSTEM CANCERS, EPENDYMOMAS, IPIDERMOID CARCINOMAS, FIBROSARCOMAS, GASTRIC CANCERS, GASTROINTESTINAL CANCERS, GLIOBLASTOMAS, GYNECOLOGIC CANCERS, HEAD AND NECK CANCERS, HEMANGIOMAS, HEPATOMAS, HODGKIN'S LYMPHOMAS, LEUKEMIA, LIVER CANCERS, LUNG CANCERS, LYMPHOMAS, MEDULLOBLASTOMAS, MENINGIOMAS, MESOTHELAIOMAS, METASTASES, MYBLOMAS, NEOPLASIAS, NEURECTODERMAL CANCERS, NEUROBLASTOMAS, NEUROFIBROMAS, NEUROFIBROSARCOMAS, NEURONAL CANCERS, NON-HODGKIN'S LYMPHOMAS, OLIGODENDROGLIOMAS, PANCREATIC CANCERS, PEDIATRIC CANCERS, PENILE CANCER, PITUTIARY ADENOMAS, PLEURAL CANCERS, RENAL CELL CARCINOMAS, SARCOMAS, SCHWANNOMAS, SKIN CANCERS, SQAMOUS CELL CARCINOMAS, TESTICULAR CANCERS, THYROID CANCERS, THYROID TUMOURS, UNINARY TRACT CANCERS

Type Code

Type

GS0051

PHARMACEUTICAL AND VETERINARY MEDICAL PRODUCTS FOR MEDICAL PURPOSES, NAMELY, PHARMACEUTICAL PREPARATIONS FOR USE IN TREATING THE SKIN DISEASES OF WARTS, GENITAL WARTS, ACTINIC KERATOSIS, PSORIASIS, DERMATITIS, HERPES, ALOPECIA, ATOPIC DERMATITIS, CUTANEOUS ATOPY, CUTANEOUS T-CELL LYMPHOMA, DARRIER'S DISEASE, DARTROUD DISTHESIS, DERMATITIS, ECZEMA, GENITAL HERPES, HERPES, HYPERKERATOSIS, HYPERPIGMENTATION, HYPERPLASIA OF THE EPIDERMIS, HYPOPIGMENTATION, ICHTHYOSIS, INCREASED PROLIFERATION OF SKIN CELLS, KELOIDS, LENTIGO, LICHEN PLANUS, MELASMA, MOLLUSCUM, CONTAGIOSUM, MYCOSIS FUNGOIDES, NEOPLASIAS, NEURODERMITIS, PIGMENTATION DISORDERS, POROKERATOSIS OF MIBELLI, PSORIASIS, REMOVAL OF TATOOS, ROSACEA, SEBORRHEA, SHINGLES, SKIN DISEASES RELATED TO INFLAMMATORY PROCESSES OF SKIN CELLS, SKIN ULCERS, VITILIGO, WARTS, XEROSIS, AND MEDICATED SKIN PREPARATIONS FOR USE IN TREATING THE TUMOROUS DISEASES OF GLIOMA, CARCINOMA OF THE COLON, OVARIAN CARCINOMA, CERVICAL CARCINOMA, CARCINOMA OF THE PROSTATE, MELANOMA, ASTROCYTOMAS, BASEL CELL CARCINOMAS, BILIARY CANCERS, BLADDER CANCERS, BONE CANCERS, BRAIN CANCERS, BREAST CANCERS, CARCINOMAS, CERVICAL CANCERS, CERVICAL INTRAEPITHELIAL NEOPLASIAS, COLORECTAL CANCERS, ENDROCRINE SYSTEM CANCERS, EPENDYMOMAS, IPIDERMOID CARCINOMAS, FIBROSARCOMAS, GASTRIC CANCERS, GASTROINTESTINAL CANCERS, GLIOBLASTOMAS, GYNECOLOGIC CANCERS, HEAD AND NECK CANCERS, HEMANGIOMAS, HEPATOMAS, HODGKIN'S LYMPHOMAS, LEUKEMIA, LIVER CANCERS, LUNG CANCERS, LYMPHOMAS, MEDULLOBLASTOMAS, MENINGIOMAS, MESOTHELAIOMAS, METASTASES, MYBLOMAS, NEOPLASIAS, NEURECTODERMAL CANCERS, NEUROBLASTOMAS, NEUROFIBROMAS, NEUROFIBROSARCOMAS, NEURONAL CANCERS, NON-HODGKIN'S LYMPHOMAS, OLIGODENDROGLIOMAS, PANCREATIC CANCERS, PEDIATRIC CANCERS, PENILE CANCER, PITUTIARY ADENOMAS, PLEURAL CANCERS, RENAL CELL CARCINOMAS, SARCOMAS, SCHWANNOMAS, SKIN CANCERS, SQAMOUS CELL CARCINOMAS, TESTICULAR CANCERS, THYROID CANCERS, THYROID TUMOURS, UNINARY TRACT CANCERS

Trademark Filing History

Description	Date	Event Coding
ASSIGNED TO EXAMINER	2003-11-11	1 DOCK D:Assigned to Examiner
NON-FINAL ACTION E-MAILED	2003-12-02	2 GNRT F:First Action
PAPER RECEIVED	2004-05-21	3 MAIL I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2004-05-21	4 CRFA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2004-05-21	5 CRFA I:Incoming Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2004-07-06	6 TCCA I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2004-08-06	7 CNSA O:Outgoing Correspondence
ASSIGNED TO LIE	2004-08-17	8 ALIE A:Allowance for Publication
ASSIGNED TO LIE	2004-08-19	9 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED	2004-08-19	10 PREV O:Outgoing Correspondence
NOTICE OF PUBLICATION	2004-09-29	11 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2004-10-19	12 PUBO A:Allowance for Publication
REGISTERED-PRINCIPAL REGISTER	2005-01-11	13 R.PR A:Allowance for Publication
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2009-11-24	14 TCCA I:Incoming Correspondence
CANCELLED SEC. 8 (6-YR)	2014-09-03	15 C8.. O:Outgoing Correspondence

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
YUROXAN 78264418 2917240 Dead/Cancelled	MediGene AG 2003-06-19
YUROXAN 77942356 4040189 Dead/Cancelled	MediGene AG 2010-02-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.